Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 71, 2011 - Issue 2
Submit an article Journal homepage
190
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Effects of the vasopressin agonist terlipressin on plasma cAMP and ENaC excretion in the urine in patients with cirrhosis and water retention

Aleksander Krag Department of Gastroenterology, Hvidovre University Hospital, Faculty of Health Sciences, University of Copenhagen, Denmark; Department of Clinical Physiology, Hvidovre University Hospital, Faculty of Health Sciences, University of Copenhagen, DenmarkCorrespondence[email protected]
,
Erling B. Pedersen Department of Medical Research and Department of Medicine, Holstebro Hospital, Denmark
,
Søren Møller Department of Clinical Physiology, Hvidovre University Hospital, Faculty of Health Sciences, University of Copenhagen, Denmark
&
Flemming Bendtsen Department of Gastroenterology, Hvidovre University Hospital, Faculty of Health Sciences, University of Copenhagen, Denmark
Pages 112-116 | Received 16 Jun 2010, Accepted 25 Oct 2010, Published online: 16 Nov 2010

References

  • Ioannou G, Doust J, Rockey DC. Terlipressin for acute esophageal variceal hemorrhage. Cochrane Database Syst Rev 2003;CD002147.
  • Gluud LL, Christensen K, Christensen E, Krag A. Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome. Hepatology 2010;51: 576–84.
  • Krag A, Borup T, Møller S, Bendtsen F. Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome. Adv Ther 2008;25:1105–40.
  • Krag A, Møller S, Henriksen JH, Holstein-Rathlou NH, Larsen FS, Bendtsen F. Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome. Hepatology 2007;46:1863–71.
  • Krag A, Bendtsen F, Pedersen EB, Holstein-Rathlou NH, Møller S. Effects of terlipressin on the aquaretic system: evidence of antidiuretic effects. Am J Physiol Renal Physiol 2008;295:F1295–300.
  • Hyun JJ, Seo YS, Lee KG, Keum B, Yim HJ, Jeen YT, Chun HJ, Um SH, Kim CD, Ryu HS. Terlipressin-induced hyponatremic seizure. Scand J Gastroenterol 2010;45: 501–4.
  • Bruha R, Marecek Z, Prochazka V, Lata J, Spicak J, Ehrmann J, Kroupa R, Petrtyl J, Dolina J, Taimr P, Drastich P, Urbanek P, Vrzalova D. Double-blind randomized multicenter study comparing the efficacy and safety of 10-day to 5-day terlipressin treatment of bleeding esophageal varices. Hepatogastroenterology 2009;56:390–4.
  • Krag A, Hobolth L, Møller S, Bendtsen F. Hyponatraemia during terlipressin therapy. Gut 2010;59:417–8.
  • Hirasawa A, Shibata K, Kotosai K, Tsujimoto G. Cloning, functional expression and tissue distribution of human cDNA for the vascular-type vasopressin receptor. Biochem Biophys Res Commun 1994;203:72–9.
  • Walker BR, Childs ME, Adams EM. Direct cardiac effects of vasopressin: role of V1- and V2-vasopressinergic receptors. Am J Physiol 1988;255:H261–5.
  • Boyle WA, III, Segel LD. Direct cardiac effects of vasopressin and their reversal by a vascular antagonist. Am J Physiol 1986;251:H734–41.
  • Barrett LK, Singer M, Clapp LH. Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med 2007;35:33–40.
  • Treschan TA, Peters J. The vasopressin system: physiology and clinical strategies. Anesthesiology 2006;105: 599–612.
  • Fenton RA, Knepper MA. Mouse models and the urinary concentrating mechanism in the new millennium. Physiol Rev 2007;87:1083–112.
  • Nielsen S, Frøkiær J, Marples D, Kwon TH, Agre P, Knepper MA. Aquaporins in the kidney: from molecules to medicine. Physiol Rev 2002;82:205–44.
  • Bankir L. Antidiuretic action of vasopressin: quantitative aspects and interaction between V1a and V2 receptor-mediated effects. Cardiovasc Res 2001;51:372–90.
  • Schafer JA. Abnormal regulation of ENaC: syndromes of salt retention and salt wasting by the collecting duct. Am J Physiol Renal Physiol 2002;283:F221–35.
  • Bankir L, Fernandes S, Bardoux P, Bouby N, Bichet DG. Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans. J Am Soc Nephrol 2005;16:1920–8.
  • Ahloulay M, Dechaux M, Hassler C, Bouby N, Bankir L. Cyclic AMP is a hepatorenal link influencing natriuresis and contributing to glucagon-induced hyperfiltration in rats. J Clin Invest 1996;98:2251–8.
  • Bankir L, Martin H, Dechaux M, Ahloulay M. Plasma cAMP: a hepatorenal link influencing proximal reabsorption and renal hemodynamics? Kidney Int Suppl 1997;59:S50–6.
  • Ahloulay M, Bankir L, Lugnier C, Le BA, Poirel O, Moreau R, Lebrec D. Cyclic AMP-phosphodiesterases inhibitor improves sodium excretion in rats with cirrhosis and ascites. Liver Int 2005;25:403–9.
  • Bankir L, Ahloulay M, Devreotes PN, Parent CA. Extracellular cAMP inhibits proximal reabsorption: are plasma membrane cAMP receptors involved? Am J Physiol Renal Physiol 2002;282:F376–92.
  • Pedersen RS, Bentzen H, Bech JN, Pedersen EB. Effect of water deprivation and hypertonic saline infusion on urinary AQP2 excretion in healthy humans. Am J Physiol Renal Physiol 2001;280:F860–7.
  • Lauridsen TG, Vase H, Bech JN, Nielsen S, Pedersen EB. Direct effect of methylprednisolone on renal sodium and water transport via the principal cells in the kidney. Eur J Endocrinol 2010;162:961–9.
  • Lauridsen TG, Vase H, Starklint J, Bech JN, Pedersen EB. Protein-enriched diet increases water absorption via the aquaporin-2 water channels in healthy humans. Nephrol Dial Transplant 2010;25:2502–10.
  • Perucca J, Bichet DG, Bardoux P, Bouby N, Bankir L. Sodium excretion in response to vasopressin and selective vasopressin receptor antagonists. J Am Soc Nephrol 2008;19:1721–31.
  • Liard JF. cAMP and extrarenal vasopressin V2 receptors in dogs. Am J Physiol 1992;263:H1888–91.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.